Skip to main content

American Addiction Centers Leads the Addiction Treatment Industry as it Launches Onsite COVID-19 Testing at all of its Treatment Centers

Written by Customer Service on . Posted in Public Companies.

BRENTWOOD, Tenn., April 22, 2020 (GLOBE NEWSWIRE) — American Addiction Centers (AAC) is leading the way in the addiction treatment industry by now testing each patient admitted to any one of its treatment centers for COVID-19. The new safety protocol is significant news for patients seeking addiction treatment in the midst of the COVID-19 pandemic.“Those struggling with addiction need those services now,” said Andrew McWilliams, AAC CEO. “We don’t need to let COVID-19 be a barrier to treatment. Last year alone, 67,000 people died from drug overdoses in the U.S. That’s almost 200 people per day dying from this deadly disease. In addition, an estimated 88,000 people die annually from alcohol-related causes.”Tests will also be available to current patients and staff exhibiting symptoms, in accordance with guidelines from the Centers of Disease Control and Prevention. AAC’s lab, Addiction Labs, worked tirelessly to piece together all the necessary elements to conduct the testing with fast turnarounds of 48 hours or less.“The safety of our patients and staff is paramount and we were not going to take ‘no’ for an answer,” said Shannon Myers, Addiction Labs supervisor. “And with that came hundreds, if not thousands, of phone calls with vendors.”The lab also went beyond standard testing protocols to ensure an accuracy rate of 95% or higher.“The accuracy of the test is extremely important to us because our clients are all in the facility together with the staff for extended periods of time,” said Joe Olechowski, Addiction Labs genetics research and development supervisor. “Providing a false negative report to a positive patient has the potential to affect the entire facility. Our test looks at three gene targets where other tests may only look at one gene target, which means the potential for false negatives is far higher.”AAC is one of a few treatment providers to have an in-house lab and the capability to offer COVID-19 testing for its patients. Addiction Labs has the capacity to run 2,400 tests a day.“We do know that behavioral health services, from a COVID-19 testing perspective, is very underserved,” said McWilliams. “Our goal is to utilize the testing we’ve developed to not only serve our patients, but to open it up to the broader behavioral health community at large.”To learn more about AAC’s COVID-19 testing and patient safety plan, visit https://americanaddictioncenters.org/covid-19-updateAbout American Addiction Centers
American Addiction Centers (OTC: AACH) is a leading provider of inpatient and outpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at www.AmericanAddictionCenters.org. We also offer several online resources for the public. Visit americanaddictioncenters.org/online-resources to learn more.Contact
Director of Corporate Communications American Addiction Centers
Joy Sutton 
jsutton@contactaac.com
615-587-7728Video accompanying this press release is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6c3e32fe-7602-42b6-81ca-45517b546176

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.